Comparison of metabolic syndrome prevalence using four different definitions - a population-based study in Finland

被引:18
作者
Haverinen, Elsi [1 ]
Paalanen, Laura [1 ]
Palmieri, Luigi [2 ]
Padron-Monedero, Alicia [3 ]
Noguer-Zambrano, Isabel [3 ]
Sarmiento Suarez, Rodrigo [3 ]
Tolonen, Hanna [1 ]
机构
[1] Finnish Inst Hlth & Welf THL, Dept Publ Hlth & Welf, Mannerheimintie 166, Helsinki 00271, Finland
[2] Ist Super Sanita ISS, Dept Cardiovasc Endocrine Metab Dis & Aging Ist S, Via Giano Bella,34, I-00161 Rome, Italy
[3] Inst Salud Carlos III, Natl Sch Publ Hlth, III,C Monforte Lemos 5, Madrid, Spain
关键词
Metabolic syndrome; Population health survey; Health examination survey; Indicators; Standardization; Diabetes; CARDIOVASCULAR-DISEASE; RISK; MANAGEMENT; INFLAMMATION; ASSOCIATION; MORTALITY; STATEMENT; TIME; MEN;
D O I
10.1186/s13690-021-00749-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Metabolic syndrome (MetS) is a public health problem in Europe, affecting all age groups. Several MetS definitions are available. The aim of this study was to compare four different MetS definitions in the Finnish adult population, to assess their agreement and to evaluate the impact of the choice of the definition on the prevalence of MetS. Methods Data from FinHealth 2017, a cross-sectional national population health survey, focusing on adults aged 25 years or older were used in the analysis (n=5687). Measured data on anthropometrics, blood pressure and biomarkers together with questionnaire data were used to classify the participants into the MetS categories according to the four definitions. The definitions chosen for the comparison were those by the World Health Organization (WHO) (1998), National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) (2004), International Diabetes Federation (IDF) (2005), and Joint Interim Statement (JIS) (2009). Results The four MetS definitions resulted in substantially different MetS prevalence: 17.7% by WHO, 33.3% by NCEP-ATP III, 41.5% by IDF, and 43.0% by JIS. Regardless of the definition used, the prevalence of MetS increased with age. The prevalence of the different components varied between the definitions, depending on the different cut-off points adopted. Out of all participants, only 13.6% were identified to have MetS according to all four definitions. Agreement between participants recognised by different MetS definitions, estimated through kappa coefficients, was almost perfect for IDF vs. JIS (0.97), strong for JIS vs. NCEP-ATP III (0.80), moderate for IDF vs. NCEP-ATP III (0.76) and weak for WHO vs. NCEP-ATP III (0.42), WHO vs. IDF (0.41) and WHO vs. JIS (0.40). Conclusions Differences between observed prevalence of MetS in Finnish men and women using different MetS definitions were large. For cross-country comparisons, as well as for trend analyses within a country, it is essential to use the same MetS definition to avoid discrepancies in classification due to differences in used definitions.
引用
收藏
页数:9
相关论文
共 49 条
  • [1] 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
    Afridi, I
    Canny, J
    Yao, CH
    Christensen, B
    Cooper, RS
    Kadiri, S
    Hill, S
    Kaplan, N
    Kuschnir, E
    Lexchin, J
    Mendis, S
    Poulter, N
    Psaty, BM
    Rahn, KH
    Sheps, SG
    Whitworth, J
    Yach, D
    Bengoa, R
    Ramsay, L
    Kaplan, N
    Mendis, S
    Poulter, N
    Whitworth, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (11) : 1983 - 1992
  • [2] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti, K. G. M. M.
    Eckel, Robert H.
    Grundy, Scott M.
    Zimmet, Paul Z.
    Cleeman, James I.
    Donato, Karen A.
    Fruchart, Jean-Charles
    James, W. Philip T.
    Loria, Catherine M.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
  • [3] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [4] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [5] 2-S
  • [6] Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
    Alkerwi, Ala'a
    Donneau, Anne-Francoise
    Sauvageot, Nicolas
    Lair, Marie-Lise
    Scheen, Andre
    Albert, Adelin
    Guillaume, Michele
    [J]. BMC PUBLIC HEALTH, 2011, 11
  • [7] Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI [10.2337/dc09-S062, 10.2337/dc10-s062]
  • [8] Health Care Utilization and Costs by Metabolic Syndrome Risk Factors
    Boudreau, D. M.
    Malone, D. C.
    Raebel, M. A.
    Fishman, P. A.
    Nichols, G. A.
    Feldstein, A. C.
    Boscoe, A. N.
    Ben-Joseph, R. H.
    Magid, D. J.
    Okamoto, L. J.
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (04) : 305 - 313
  • [9] Perfluoroalkyl substances and metabolic syndrome
    Christensen, Krista Y.
    Raymond, Michelle
    Meiman, Jon
    [J]. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2019, 222 (01) : 147 - 153
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497